We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

Back to rankings

30 hedge funds and large institutions have $20.7M invested in Alexza Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

602% more call options, than puts

Call options by funds: $7.37M | Put options by funds: $1.05M

Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
30
Increased
–
Reduced
–
Closed
–
Calls
$7.37M
Puts
$1.05M
Net Calls
+$6.32M
Net Calls Change
+$6.32M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LPA
1
Lansdowne Partners Austria
Austria
$5.26M +$5.5M +1,212,555 New
Federated Hermes
2
Federated Hermes
Pennsylvania
$2.93M +$3.06M +674,300 New
CS
3
Credit Suisse
Switzerland
$2.84M +$2.97M +654,292 New
VM
4
VHCP Management
New York
$1.74M +$1.81M +399,999 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.53M +$1.6M +353,498 New
LPLP
6
Lansdowne Partners Limited Partnership
United Kingdom
$1.33M +$1.39M +307,500 New
Morgan Stanley
7
Morgan Stanley
New York
$1.24M +$1.29M +285,115 New
KCM
8
Kennedy Capital Management
Missouri
$1.07M +$1.12M +246,473 New
BCM
9
BBT Capital Management
Texas
$575K +$601K +132,533 New
HHMI
10
Howard Hughes Medical Institute
Maryland
$429K +$448K +98,914 New
Goldman Sachs
11
Goldman Sachs
New York
$334K +$349K +76,919 New
KCG
12
Knight Capital Group
$265K +$279K +61,466 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$227K +$237K +52,280 New
BFA
14
BlackRock Fund Advisors
California
$156K +$163K +35,931 New
U
15
UBS
Switzerland
$131K +$137K +30,184 New
Northern Trust
16
Northern Trust
Illinois
$120K +$125K +27,559 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$117K +$122K +27,017 New
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$114K +$119K +26,307 New
Nomura Holdings
19
Nomura Holdings
Japan
$109K +$113K +25,044 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$86K +$89.8K +19,820 New
RCM
21
Rotella Capital Management
Washington
$43K +$45.3K +10,000 New
WAM
22
Wolverine Asset Management
Illinois
$23K +$24K +5,300 New
BA
23
BlackRock Advisors
Delaware
$16K +$17.1K +3,779 New
Wells Fargo
24
Wells Fargo
California
$13K +$13.9K +3,060 New
Citadel Advisors
25
Citadel Advisors
Florida
$7K +$7.66K +1,691 New
1
2

ALXA Hedge Fund Activity: Q2 2013 in Review

30 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2013, worth a combined $20.7M.

Buyers outnumbered sellers: 30 funds opened new ALXA positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

  • 30 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $20.7M of Alexza Pharmaceuticals Inc stock for Q2 2013.
  • 30 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +30 holders.

Based on aggregated 13F filings for Q2 2013.